---
figid: PMC8558176__18_2021_3941_Fig1_HTML
figtitle: WNT3 hypomethylation counteracts low activity of the Wnt signaling pathway
  in the placenta of preeclampsia
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8558176
filename: 18_2021_3941_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8558176/figure/Fig1/
number: F1
caption: The canonical Wnt/β-catenin pathway. A Without Wnt ligand, β-catenin in the
  cytoplasm is phosphorylated and then degraded by ubiquitination. B With Wnt ligand,
  phosphorylated GSK3β and β-catenin increase in the cytoplasm, and the latter enters
  the nucleus to regulate gene expression. LRP lipoprotein receptor-related protein,
  Dvl disheveled, APC adenomatous polyposis coli, GSK3β glycogen synthase kinase 3β,
  CK1 casein kinase 1, TCT/LEF T-cell factor/lymphocyte enhancer binding factor
papertitle: WNT3 hypomethylation counteracts low activity of the Wnt signaling pathway
  in the placenta of preeclampsia.
reftext: Linlin Zhang, et al. Cell Mol Life Sci. 2021;78(21-22):6995-7008.
year: '2021'
doi: 10.1007/s00018-021-03941-4
journal_title: Cellular and Molecular Life Sciences
journal_nlm_ta: Cell Mol Life Sci
publisher_name: Springer International Publishing
keywords: Preeclampsia | Placentas | WNT3 gene | DNA methylation | Preterm birth
automl_pathway: 0.9524982
figid_alias: PMC8558176__F1
figtype: Figure
redirect_from: /figures/PMC8558176__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8558176__18_2021_3941_Fig1_HTML.html
  '@type': Dataset
  description: The canonical Wnt/β-catenin pathway. A Without Wnt ligand, β-catenin
    in the cytoplasm is phosphorylated and then degraded by ubiquitination. B With
    Wnt ligand, phosphorylated GSK3β and β-catenin increase in the cytoplasm, and
    the latter enters the nucleus to regulate gene expression. LRP lipoprotein receptor-related
    protein, Dvl disheveled, APC adenomatous polyposis coli, GSK3β glycogen synthase
    kinase 3β, CK1 casein kinase 1, TCT/LEF T-cell factor/lymphocyte enhancer binding
    factor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HNF4A
  - LRP6
  - LRP5
  - CTNNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
---
